Plunkett Research Online: Vaxil Bio Ltd

VAXIL BIO LTD (SEEEF) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Vaxil BioTherapeutics Ltd. (TASE:VAXL), is a clinical stage company developing a new class of synthetic T-cell therapeutic and preventive vaccines with promiscuous MHC class I and II binding, based on its proprietary VaxHit technology......


VAXIL BIO LTD

Ticker: SEEEF
Exchange: GREY
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 972 89396948
Fax: 972 89396996
Address:
Nes-Ziona, 74036 Israel

Types Of Business
Industry Ranks

Industry NAICS code:

ContactsDescription

Vaxil BioTherapeutics Ltd. (TASE:VAXL), is a clinical stage company developing a new class of synthetic T-cell therapeutic and preventive vaccines with promiscuous MHC class I and II binding, based on its proprietary VaxHit technology......See More See More

$USD, In whole numbers 2017201620152014201320122011
Sales
Profits
Brands, Divisions and AffiliatesTop Salaries
Salary
Bonus
Other ThoughtsCorporate Culture